Terms: = Kidney tumors AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
126 results:
1. Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma.
Reese SW; Eismann L; White C; Villada JA; Khaleel S; Ostrovnaya I; Vazquez-Rivera K; Carlo MI; Feldman D; Lee CH; Motzer R; Voss MH; Kotecha RR; Matulewicz RS; Goh A; Coleman J; Russo P; Hakimi AA
Urol Oncol; 2024 Feb; 42(2):32.e9-32.e16. PubMed ID: 38135627
[TBL] [Abstract] [Full Text] [Related]
2. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
3. Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined
Malik M; Maqbool M; Nisar T; Akhter T; Ujan JA; Algarni AS; Joufi FAA; Alanazi SSK; Almotared MH; Bekhit MMS; Jamil M
Oncol Res; 2023; 31(6):899-916. PubMed ID: 37744271
[TBL] [Abstract] [Full Text] [Related]
4. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
5. Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy.
Huang J; Su R; Zhang C; Bao Y; Hu X; Ye X; Chen M; Wang P; Wu J; Wang Y; Tang Q; Huang Z; Zheng B; Li C; Guo J; Huang Y; Wei Q; He Z; Xue W
Urol Oncol; 2023 Oct; 41(10):434.e17-434.e25. PubMed ID: 37563078
[TBL] [Abstract] [Full Text] [Related]
6. Factors affecting survival and prognosis in surgically treated patients with spinal metastases arising from renal cell carcinoma.
Lei M; Miao J
BMC Urol; 2023 Jul; 23(1):118. PubMed ID: 37443069
[TBL] [Abstract] [Full Text] [Related]
7. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance ccnd1 mRNA stability.
Yang F; Ma Q; Huang B; Wang X; Pan X; Yu T; Ran L; Jiang S; Li H; Chen Y; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Li W; Xiao B
J Transl Med; 2023 Jun; 21(1):402. PubMed ID: 37340423
[TBL] [Abstract] [Full Text] [Related]
8. Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway.
Li L; Li M; Zheng J; Li Z; Chen X
Aging (Albany NY); 2023 Jun; 15(11):4757-4773. PubMed ID: 37263638
[TBL] [Abstract] [Full Text] [Related]
9. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
10. Proteotranscriptomic Discrimination of Tumor and Normal Tissues in Renal Cell Carcinoma.
Bartha Á; Darula Z; Munkácsy G; Klement É; Nyirády P; Győrffy B
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901940
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy.
Chen X; Zhang T; Zhan X; Zang X; Zhai X; Wan Z; Ge M; Tan M; Gu J; Xu D
Genet Res (Camb); 2023; 2023():2355891. PubMed ID: 36741922
[TBL] [Abstract] [Full Text] [Related]
12. CD70-Targeted Micelles Enhance HIF2α siRNA Delivery and Inhibit Oncogenic Functions in Patient-Derived Clear Cell Renal Carcinoma Cells.
Trac N; Oh HS; Jones LI; Caliliw R; Ohtake S; Shuch B; Chung EJ
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500549
[TBL] [Abstract] [Full Text] [Related]
13. Acute kidney injury in advanced lung cancer patients treated with PD-1 inhibitors: a single center observational study.
Liu K; Qin Z; Ge Y; Bian A; Xu X; Wu B; Xing C; Mao H
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5061-5070. PubMed ID: 36326913
[TBL] [Abstract] [Full Text] [Related]
14. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract] [Full Text] [Related]
15. Long term exposure to air pollution and kidney parenchyma cancer - Effects of low-level air pollution: a Study in Europe (ELAPSE).
Hvidtfeldt UA; Taj T; Chen J; Rodopoulou S; Strak M; de Hoogh K; Andersen ZJ; Bellander T; Brandt J; Fecht D; Forastiere F; Gulliver J; Hertel O; Hoffmann B; Jørgensen JT; Katsouyanni K; Ketzel M; Lager A; Leander K; Ljungman P; Magnusson PKE; Nagel G; Pershagen G; Rizzuto D; Samoli E; So R; Stafoggia M; Tjønneland A; Vermeulen R; Weinmayr G; Wolf K; Zhang J; Zitt E; Brunekreef B; Hoek G; Raaschou-Nielsen O
Environ Res; 2022 Dec; 215(Pt 2):114385. PubMed ID: 36154858
[TBL] [Abstract] [Full Text] [Related]
16. Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.
Tamukong PK; Kuhlmann P; You S; Su S; Wang Y; Yoon S; Gong J; Figlin RA; Janes JL; Freedland SJ; Halabi S; Small EJ; Rini BI; Kim HL
Urol Oncol; 2022 Nov; 40(11):495.e1-495.e10. PubMed ID: 35973929
[TBL] [Abstract] [Full Text] [Related]
17. The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.
Patel SA; Hirosue S; Rodrigues P; Vojtasova E; Richardson EK; Ge J; Syafruddin SE; Speed A; Papachristou EK; Baker D; Clarke D; Purvis S; Wesolowski L; Dyas A; Castillon L; Caraffini V; Bihary D; Yong C; Harrison DJ; Stewart GD; Machiela MJ; Purdue MP; Chanock SJ; Warren AY; Samarajiwa SA; Carroll JS; Vanharanta S
Nature; 2022 Jun; 606(7916):999-1006. PubMed ID: 35676472
[TBL] [Abstract] [Full Text] [Related]
18. [MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting ccnd1].
Lei K; Xie W; Sun T; Liu Y; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):712-717. PubMed ID: 35673915
[TBL] [Abstract] [Full Text] [Related]
19. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry.
Meagher MF; Mir MC; Autorino R; Minervini A; Kriegmair M; Maurer T; Porpiglia F; Van Bruwaene S; Linares E; Hevia V; Musquera M; Roussel E; Pavan N; Antonelli A; Zhang S; Ghali F; Patel D; Javier-Desloges J; Bradshaw A; Rubio J; Guruli G; Tracey A; Campi R; Albersen M; Furlan M; McKay RR; Derweesh IH
Clin Genitourin Cancer; 2022 Aug; 20(4):326-333. PubMed ID: 35585014
[TBL] [Abstract] [Full Text] [Related]
20. Cancer risk among firefighters and police in the Ontario workforce.
Sritharan J; Kirkham TL; MacLeod J; Marjerrison N; Lau A; Dakouo M; Logar-Henderson C; Norzin T; DeBono NL; Demers PA
Occup Environ Med; 2022 Aug; 79(8):533-539. PubMed ID: 35354650
[TBL] [Abstract] [Full Text] [Related]
[Next]
